FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 41 filers reported holding FINCH THERAPEUTICS GROUP INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $25,000 | – | 15,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRB Advisors LP | 550,000 | $7,739,000 | 1.75% |
| Bleichroeder LP | 810,416 | $11,403,000 | 1.72% |
| Aperture Investors, LLC | 319,122 | $4,490,000 | 0.51% |
| Ikarian Capital, LLC | 325,000 | $4,573,000 | 0.37% |
| SECTORAL ASSET MANAGEMENT INC | 300,399 | $4,227,000 | 0.34% |
| Baupost Group | 1,208,159 | $16,693,000 | 0.14% |
| Proficio Capital Partners LLC | 112,059 | $1,577,000 | 0.12% |
| LIGHT STREET CAPITAL MANAGEMENT, LLC | 168,330 | $2,368,000 | 0.10% |
| MSD Partners, L.P. | 235,294 | $3,311,000 | 0.09% |
| PURA VIDA INVESTMENTS, LLC | 71,552 | $1,007,000 | 0.03% |